Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(18%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_4
5
45%
Ph phase_2
2
18%
Ph not_applicable
1
9%
Ph phase_3
3
27%

Phase Distribution

0

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
5(45.5%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Other(1)

Detailed Status

Completed7
Recruiting2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 33 (27.3%)
Phase 45 (45.5%)
N/A1 (9.1%)

Trials by Status

recruiting218%
unknown19%
not_yet_recruiting19%
completed764%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11